Related Experiment Video
Updated: Jul 4, 2026
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report
Yuki Akazawa1, Takashi Sato1, Yuri Yagami1
1Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Background:
Transformation to small cell carcinoma, squamous cell carcinoma, and rarely, pleomorphic carcinoma (PC) has been reported to be found in EGFR-mutated lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). However, evidence for underlying factors including genomic profiles associated with PC transformation has been lacking.
Case:
We report a case of EGFR-mutated lung adenocarcinoma that transformed to PC confirmed by an autopsy after stereotactic radiotherapy and treatment with EGFR-TKIs. Comprehensive genomic profiling of the autopsy tissue revealed BRAF G466A, KRAS L19F, and NF1 Q2324* mutations in addition to EGFR E746_A750del. Anti-cancer treatments with radiation and EGFR-TKIs accompanying these gene alterations might induce the histological transformation and resistance to EGFR-TKIs.
Conclusion:
This report adds an insight into the involvement of genetic events in histological transformation in EGFR-mutated lung cancer.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
